ArticleBMC medicine2026
Clustering of multimorbidity in stroke and transient ischaemic attack survivors: a population-based study.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundStroke and transient ischaemic attack (TIA) survivors frequently experience multiple long-term conditions (multimorbidity) placing substantial demands on healthcare systems. Moving away from a single-disease approach could lead to more efficient and effective care for stroke survivors with multimorbidity. However, it is unclear how to categorise the stroke population to achieve this. To inform care, this population-based study identified and described clusters of stroke survivors with multimorbidity.
methodsUsing the Clinical Practice Research Datalink GOLD database, we identified 69,372 adult stroke/TIA survivors who were currently registered with a general practice on the 1st July 2017. We defined multimorbidity as the co-occurrence of ≥ 2 of 36 long-term conditions (including stroke/TIA) and divided patients into four age strata (< 45, 45-64, 65-84, ≥ 85). Within each stratum, Latent Class Analysis identified classes of co-morbid stroke survivors based on statistical diagnostics, clustering interpretation and clinical input. We investigated the validity of our findings, using a training and a test set. We described clusters according to prevalence of long-term conditions, demographic factors (age, gender, ethnicity, smoking, BMI) and health outcomes (mortality, hospital admissions, primary care consultations, prescriptions).
resultsIn the UK, 94·7% of adult stroke/TIA survivors live with at least one additional long-term condition, with a median of five conditions per patient. We identified 12 clusters. Among 45-64-year-olds, the "alcohol and substance misuse" (6%) and the "established cardiovascular disease" (5%) clusters, have the highest mortality, while the "lower morbidity, better outcomes" cluster included 49% of patients. In ages 65-84, the "poor mental health" cluster (25%) exhibits the highest mortality. Among patients [Formula: see text]85, the "dementia-dominant" cluster had the highest rates of mortality, whereas the "established cardiovascular disease" cluster had the most hospital admissions. In each age strata, a cluster with increased mental health needs, and another with lower rates of multimorbidity and the best health outcomes could be identified.
conclusionsInternally validated clusters of stroke survivors can be identified with distinct patterns of multimorbidity, healthcare utilisation, and mortality. By understanding these clusters, more targeted, efficient, and integrated models of post-stroke care can be designed to better address the overall healthcare needs of stroke survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.